MSB 2.12% 92.5¢ mesoblast limited

Ann: Update on Scheduled FDA Advisory Committee Meeting, page-12

  1. 701 Posts.
    lightbulb Created with Sketch. 215
    "Mesoblast has extensively prepared for the meeting"
    "Ryoncil is under Priority review by the FDA"
    "There are currently no other FDA approved treatments"

    What else they could have said to calm down the nerves?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
-0.020(2.12%)
Mkt cap ! $1.050B
Open High Low Value Volume
93.0¢ 93.5¢ 92.0¢ $1.390M 1.501M

Buyers (Bids)

No. Vol. Price($)
9 17630 92.5¢
 

Sellers (Offers)

Price($) Vol. No.
93.0¢ 121028 29
View Market Depth
Last trade - 14.21pm 09/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.